hotspot -WSS

hotspot

author：Wikipedia 2025-10-02 01:04:43 - browse：4

Element Biosciences exterior -- biotech coverage from STAT — Element Biosciences exterior Element Biosciences

SAN DIEGO — Companies racing to read the genome accurately, quickly, and affordably have hit a snag recently, with several firms reporting that their growth has slowed, stalled, or reversed. Upstart Element Biosciences is hoping it can succeed despite the challenging market conditions.

The San Diego firm launched a $290,000 sequencer, dubbed Aviti, in March 2022 and now has 150 instruments installed in more than 25 countries, according to a sales update Element shared with STAT. The modest growth comes at a time when some other players are struggling. Singular Genomics announced layoffs of 20% of its workforce earlier this year after the lackluster launch of its own sequencer. And Pacific Biosciences recently laid off nearly 200 employees after reporting disappointing first-quarter sales.

Element still has a long way to go in its bid to rival Illumina, a genomics giant that dominates 80% of the sequencing market and has more than 23,000 instruments in use around the world. That includes the NextSeq 2000, a $335,000 sequencer with a similar output to Aviti. Element is betting its blend of accuracy and a more moderate price point can help it carve out a niche of academic and biopharma customers.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Novel spinal cord stimulator treats paralysis without surgery

hotspot

leisure time

WSS

Indian pharmaceutical industry in denial over drug

Mass General totes up its waste in a move to tackle climate change

Wife of Gilgo Beach murder suspect files for divorce, court filing shows

AltruBio raises $225 million to develop ulcerative colitis drug

DeSantis talks Trump, trans issues and 'what wokeness is'

Chemotherapy before breast cancer surgery might fuel metastasis

explore

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

explore

Heart attack and stroke risk calculators need revising

Mass General totes up its waste in a move to tackle climate change

Medicare details structure of new drug price negotiation program

Tesla recalling nearly 16,000 of its 2021

Medicare details structure of new drug price negotiation program

Mass General totes up its waste in a move to tackle climate change

Medical leaders decry Supreme Court decision on affirmative action

Warren pushes Witty on UnitedHealth's control over physicians

ChatGPT in medicine: STAT answers readers' burning questions

The creative science of coining drug names

focus

Brain MRIs reveal impact of 'toxic stress' on Black children

Why Congress must ban federal programs from using QALYs

Judge rejects Trump's request to move Stormy Daniels hush

Warren pushes Witty on UnitedHealth's control over physicians

Lawmakers grill UnitedHealth CEO on Change cyberattack

Wildfires rage amid heat wave in Greece, prompting evacuations and call for European support

hotspot

hotspot

leisure time

explore